Opinion: GenAI Is Not a One-Size-Fits-All Solution for Regulatory Operations

Tempting as it may be to turn to full automation to meet burdensome requirements, the potential for hallucination and other issues means biopharma companies must proceed with caution.
{Categories} _Category: Takes{/Categories}
{URL}https://www.biospace.com/article/opinion-genai-is-not-a-one-size-fits-all-solution-for-regulatory-operations/{/URL}
{Author}unknown{/Author}
{Image}https://www.biospace.com/getasset/11fa5c8a-5abd-41bd-89e5-be302c835cd3/{/Image}
{Keywords}{/Keywords}
{Source}POV{/Source}
{Thumb}{/Thumb}